Cara Therapeutics Inc (CARA)
0.7685
-0.01
(-1.61%)
USD |
NASDAQ |
May 03, 10:14
Cara Therapeutics Shareholders Equity (Quarterly): 57.08M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.08M |
| September 30, 2023 | 85.64M |
| June 30, 2023 | 108.93M |
| March 31, 2023 | 136.60M |
| December 31, 2022 | 158.78M |
| September 30, 2022 | 184.82M |
| June 30, 2022 | 204.42M |
| March 31, 2022 | 204.12M |
| December 31, 2021 | 227.52M |
| September 30, 2021 | 207.19M |
| June 30, 2021 | 203.47M |
| March 31, 2021 | 230.46M |
| December 31, 2020 | 249.00M |
| September 30, 2020 | 127.85M |
| June 30, 2020 | 140.93M |
| March 31, 2020 | 160.47M |
| December 31, 2019 | 186.71M |
| September 30, 2019 | 211.89M |
| June 30, 2019 | 99.54M |
| March 31, 2019 | 114.52M |
| December 31, 2018 | 133.63M |
| September 30, 2018 | 149.53M |
| Date | Value |
|---|---|
| June 30, 2018 | 73.08M |
| March 31, 2018 | 72.10M |
| December 31, 2017 | 86.78M |
| September 30, 2017 | 99.07M |
| June 30, 2017 | 109.22M |
| March 31, 2017 | 29.27M |
| December 31, 2016 | 50.72M |
| September 30, 2016 | 71.80M |
| June 30, 2016 | 82.59M |
| March 31, 2016 | 94.93M |
| December 31, 2015 | 105.04M |
| September 30, 2015 | 113.86M |
| June 30, 2015 | 42.47M |
| March 31, 2015 | 47.42M |
| December 31, 2014 | 51.66M |
| September 30, 2014 | 55.34M |
| June 30, 2014 | 61.57M |
| March 31, 2014 | 64.73M |
| December 31, 2013 | 11.51M |
| September 30, 2013 | 13.59M |
| December 31, 2012 | 2.439M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
57.08M
Minimum
Dec 2023
249.00M
Maximum
Dec 2020
167.65M
Average
184.82M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 130.99M |
| Stereotaxis Inc | 21.92M |
| Cerus Corp | 52.65M |
| Avid Bioservices Inc | 180.17M |
| Rigel Pharmaceuticals Inc | -28.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.84M |
| Total Liabilities (Quarterly) | 68.76M |
| Current Ratio | 4.539 |